Transfusion-transmitted human immunodeficiency virus (HIV) from seroconverting donors is rare in England and Wales: Results from HIV lookback, October 1995 through December 2008

Transfusion

Volumn 51, Issue 6, 2011, Pages 1339-1345

  Byrne, Lisa ^a   Brant, Lisa J ^a   Davison, Katy ^a   Hewitt, Patricia ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD DONOR; ERYTHROCYTE TRANSFUSION; FEMALE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; POLYMERASE CHAIN REACTION; SEROCONVERSION; TORQUE TENO VIRUS; UNITED KINGDOM;

BLOOD DONORS; BLOOD TRANSFUSION; ENGLAND; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; WALES;

EID: 79958856179     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02996.x     Document Type: Article

References (31)

1. Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, van Drimmelen H, David B, Lelie N, De Micco P,. Sensitivity of two hepatitis B virus, hepatitis C virus and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels. Transfusion 2009; 49: 301-10.
2. Malm K, Von Sydow M, Andersson S,. Performance of three automated fourth-generation combined HIV antigen/antibody assays in large-scale screening of blood donors and clinical samples. Transfus Med 2009; 19: 78-88.
3. Soldan K, Davison K, Dow BC,. Estimates of the frequency of HBV, HCV and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003. Eurosurveillance 2005; 10: 9-10.
4. Goldman M, Patterson L, Long A,. Recent Canadian experience with targeted hepatitis C virus lookback. Transfusion 2006; 46: 690-4.
5. Learmont J, Phillips R, Bickerton I,. The value of lookback to understanding blood-borne infectious diseases: the New South Wales' HIV experience. Transfus Med Rev 2002; 16: 315-24. (Pubitemid 35266249)
6. The English National Blood Service HCV Lookback Collation Collaborators. Transfusion transmission of HCV infection before anti-HCV testing of blood donations in England: results of the national HCV lookback program. Transfusion 2002; 42: 1146-53.
7. Morris K, Bharucha C,. Completed hepatitis C lookback in Northern Ireland. Transfus Med 1997; 7: 269-75. (Pubitemid 28051960)
8. Nubling C, Heiden M, Chudy M, Kress J, Seitz R, Keller-Stanislawski B, Funk M,. Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions. Transfusion 2008; 49: 1850-8.
9. Perry KR, Ramskill S, Eglin RP, Barbara JAJ, Parry JV,. Improvement in the performance of HIV screening kits. Transfus Med 2008; 18: 228-40.
10. Gilbart VL, Raeside F, Evans BG, Mortimer JY, Arnold C, Gill ON, Clewley JP, Goldberg D,. Unusual HIV transmissions through blood contact: analysis of cases reported in the United Kingdom to December 1997. Commun Dis Public Health 1998; 1: 108-13.
11. Gilbart VL, Evans BG,. The role of comprehensive follow-up in the investigation of risk status for individuals with known HIV infection. 1998 International AIDS Conference, Geneva. 1998.
12. Mortimer JY,. Salathiel. "Soundex" codes of surnames provide confidentiality and accuracy in a national HIV database. Commun Dis Rep CDR Rev 1995; 5: R183-6.
13. Serious Hazards of Transfusion Steering Committee. Serious hazards of transfusion: annual report 2003 [monograph on the Internet]. Manchester (UK): SHOT Office; 2004. Available from
14. Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, Pappalardo B, Kleinman SH, NHLBI-REDS NAT Study Group. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005; 45: 254-64. (Pubitemid 40180144)
15. Phelps R, Robbins K, Liberti T, Machuca A, Leparc G, Chamberland M, Kalish M, Hewlett I, Folks T, Lee L, McKenna M,. Window-period human immunodeficiency virus transmission to two recipients by an adolescent donor. Transfusion 2004; 44: 929-33. (Pubitemid 38738425)
16. Ling AE, Robbins KE, Brown TM, Dunmire V, Thoe SY, Wong SY, Leo YS, Teo D, Gallarda J, Phelps B, Chamberland ME, Busch MP, Folks TM, Kalish ML,. Failure of routine HIV-1 tests in a case involving transmission with pre-seroconversion blood components during the infectious window period. JAMA 2000; 284: 210-4. (Pubitemid 30460865)
17. Harritshoj LH, Dickmeiss E, Hansen MB, Ullum H, Jorgensen LB, Gerstoft J,. Transfusion-transmitted human immunodeficiency virus infection by a Danish blood donor with a very low viral load in the pre-seroconversion window phase. Transfusion 2008; 40: 2026-8.
18. Delwart E, Kalmin N, Jones T, Ladd D, Foley B, Tobler L, Tsui R, Busch M,. First report of human immunodeficiency virus transmission on an RNA-screened blood donation. Vox Sang 2004; 86: 171-7. (Pubitemid 38529506)
19. Hourfar M, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch M, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ,; German Red Cross NAT Study Group. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus. Transfusion 2008; 48: 1558-66.
20. Stramer S, Chambers L, Page P,. Wagner A and Gibble J. Hird. Reported case of breakthrough HIV transmission from NAT screened blood. Transfusion 2003; 43 Suppl 9: 40A-1A.
21. Safe supplies: testing the nation. Annual review from the NHS Blood and Transplant Epidemiology Unit. London, August 2010; 2009 [cited 2010 Sep 24]. Available from
22. Polizzotto MN, Wood EM, Ingham H, Keller AJ, Australian Red Cross Blood Service Donor and Product Safety Team. Reducing the risk of transfusion- transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006. Transfusion 2008; 48: 55-63.
23. Van der Bij AK, Coutinho RA, Ven der Poel CL,. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands. Transfusion 2006; 46: 1729-36. (Pubitemid 44435725)
24. Orton SL, Stramer SL, Dodd RY, Alter MJ,. Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCV. Transfusion 2004; 44: 275-81. (Pubitemid 38236391)
25. AuBuchon J,. Paving with good intentions: learning from HCV lookback. Transfusion 2000; 40: 1153-6.
26. Serious Hazards of Transfusion Steering Committee. Serious hazards of transfusion: annual report 1996 [monograph on the Internet]. Manchester (UK): SHOT Office; 1997. Available from
27. HIV infection transmitted through transfusion. CDR Wkly 1997; 7: 137.
28. Health Protection Agency. HIV in the United Kingdom: 2009 report. London, 2009 [cited 2010 Sep 24]. Available from
29. Hollinger F, Dodd R,. Hepatitis B virus traceback and lookback: factors to consider. Transfusion 2009; 49: 176-84.
30. Stramer S, Foster G, Dodd R,. Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and current HTLV-I and II confirmatory algorithm, 1999 to 2004. Transfusion 2006; 46: 703-7.
31. Callum J, Pinkerton P, Coovadia A,. Thomson A and Dewsbury F. An evaluation of the process and costs associated with targeted lookbacks for HCV and general notification of transfusion recipients. Transfusion 2000; 40: 1169-75.